SCHEMBL29786331

SCHEMBL29786331

O=C(NCCc1ccccc1)n1ccnc1-c1ccc(F)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.46
RXFP1 Q9HBX9 1/20 0.41
RAB9A P51151 7/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
BCHE P06276 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ASAH1 Q13510 2/20 0.40
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
NPC1 O15118 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29786337 0.88 HIF1A (0.46) HIF1ARXFP1RAB9AALDH1A1CYP1A2
SCHEMBL29786281 0.84 HIF1A (0.43) HIF1ARXFP1RAB9AALDH1A1CYP1A2
SCHEMBL29786257 0.84 HPGD (0.44) HIF1ARXFP1RAB9AALDH1A1CYP1A2
SCHEMBL29786260 0.79 MCHR1 (0.45) HIF1ARXFP1RAB9AALDH1A1CYP1A2
SCHEMBL24810560 0.76 HIF1A (0.46) HIF1ARAB9AALDH1A1CYP1A2BCHE
SCHEMBL29786381 0.75 ASAH1 (0.39) HIF1ARXFP1RAB9AALDH1A1CYP1A2
SCHEMBL24810745 0.74 ASAH1 (0.49) RAB9AALDH1A1CYP1A2BCHECYP3A4
SCHEMBL29003728 0.72 RAB9A (0.47) RXFP1RAB9AALDH1A1CYP1A2BCHE
SCHEMBL30194504 0.70 ASAH1 (0.60) ASAH1SMN1; SMN2HPGD
SCHEMBL29786310 0.70 ASAH1 (0.41) HIF1ARXFP1RAB9AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed